申请人:Bristol-Myers Squibb Company
公开号:EP0345808A1
公开(公告)日:1989-12-13
A compound of Formula I and the pharmaceutically acceptable acid addition salts thereof,
wherein
R1 and R2 are independently selected from lower, meaning C1-4, alkyl or hydrogen;
R3, R4, R8 and R9 are independently selected from hydrogen, lower alkyl, lower alkoxy, carbamide, halogen, trifluoromethyl and thio-lower alkyl, with the proviso that R8 and R9 cannot both be hydrogen at the same time;
A is a Cs-7 cycloalkanyl or cycloalkenyl ring, or
A is
wherein n is an integer from 1 to 3 and R5 is the same as R1; and
R6 and R7 are independently selected from hydrogen, methyl or R6 and R7 can be taken together as a methylene bridge, useful as antidepressants.
式 I 的化合物及其药学上可接受的酸加成盐、
其中
R1 和 R2 独立选自低级(即 C1-4)烷基或氢;
R3、R4、R8 和 R9 独立选自氢、低级烷基、低级烷氧基、碳酰胺、卤素、三氟甲基和硫代低级烷基,但 R8 和 R9 不能同时为氢;
A 是 Cs-7 环烷基或环烷烯基环,或
A 是
其中 n 为 1 至 3 的整数,R5 与 R1 相同;以及
R6 和 R7 分别独立地选自氢、甲基或 R6 和 R7 可一起作为亚甲基桥,可用作抗抑郁剂。